慢慢流出 发表于 2025-3-25 04:53:25

Submitted on: 16 June 2006.
Revised on: 14 September 2006.
Accepted on: 05 October 2006.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

心痛 发表于 2025-3-25 11:08:23

Submitted on: 23 December 2000.
Revised on: 04 February 2001.
Accepted on: 06 March 2001.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

裂缝 发表于 2025-3-25 13:29:41

Submitted on: 30 July 2011.
Revised on: 12 October 2011.
Accepted on: 25 November 2011.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

THROB 发表于 2025-3-25 16:38:27

Submitted on: 23 August 2003.
Revised on: 22 November 2003.
Accepted on: 14 January 2004.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

发怨言 发表于 2025-3-25 20:12:55

http://reply.papertrans.cn/1/47/4697/4697-25.png

悲观 发表于 2025-3-26 03:00:22

http://reply.papertrans.cn/1/47/4697/4697-26.png

参考书目 发表于 2025-3-26 04:49:31

http://reply.papertrans.cn/1/47/4697/4697-27.png

出生 发表于 2025-3-26 12:15:37

http://reply.papertrans.cn/1/47/4697/4697-28.png

Classify 发表于 2025-3-26 13:53:12

Submitted on: 22 October 1998.
Revised on: 06 January 1999.
Accepted on: 04 February 1999.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

Minuet 发表于 2025-3-26 16:58:16

http://reply.papertrans.cn/1/47/4697/4697-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊CANCER IMMUNOLOGY IMMUNOTHERAPY 2024/2025影响因子:4.605 (CANCER IMMUNOL IMMUN) (0340-7004). (ONCOLOGY)(肿瘤学)Science Ci